Brivaracetam for the treatment of refractory epilepsy in patients with prior exposure to levetiracetam: A retrospective outcome analysis

Anniko Snoeren*, Marian H J M Majoie, Koen C F M Fasen, Dominique M Ijff

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)102-107
Number of pages6
JournalSEIZURE-EUROPEAN JOURNAL OF EPILEPSY
Volume96
Early online date12 Feb 2022
DOIs
Publication statusPublished - Mar 2022

Keywords

  • ADJUNCTIVE BRIVARACETAM
  • ADULTS
  • Anti-epileptic drug
  • Behaviour
  • Brivaracetam
  • DOUBLE-BLIND
  • EFFICACY
  • GLYCINE
  • Levetiracetam
  • PARTIAL-ONSET SEIZURES
  • PHASE-III
  • TOLERABILITY
  • Treatment-emergent adverse events

Cite this